NTBL Notable Labs Ltd: Sotuvning sof marjinal rentabelligi

Notable Labs Ltd - NTBL emitenti grafik logotipi

Oylik savdo marjasi dinamikasi terapiya prognozlash IT tizimi doirasidagi tor ixtisoslashuv risklarini namoyish etmoqda, 0.00 qiymati esa joriy metrikaga mos keladi. Notable Labs, Ltd. (NTBL) dori vositalarini tanlash uchun aniqlik onkologiyasi xizmatlari orqali daromad keltiradi. Ekotizim davolash samaradorligini aniqlash uchun jonli hujayralar tahlilini AI bilan integratsiya qilib, bemorlarning yashab qolish navigatorini yaratadi.

Notable Labs Corp (NTBL) Sof marja: 21.02.2024 - 02.11.2024 davri uchun

Notable Labs Corp (NTBL) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Fundamental baholash:notablelabs.com - NTBL
Notable Labs Inc. tayyor mahsulotlari

Notable Labs, Ltd. (NTBL) o'zining B2B segmentini kengaytirish orqali onkologik dori vositalarining samaradorligini bashorat qiluvchi IT platformasini kengaytirmoqda. Sof foyda marjasi tendentsiyasi barcha operatsion va soliq xarajatlarini qoplagandan keyin qolgan foyda qismini aks ettiradi. Joriy qiymatlarni tarixiy tendentsiya bilan solishtirish biznes samaradorligidagi strukturaviy o'zgarishlarni aniqlash imkonini beradi. Ushbu ko'rsatkich kompaniyaning daromadni sof foydaga aylantirish qobiliyatini o'lchaydi, bu esa bozorlarni egallash jarayonida aktivlar qiymatini baholash uchun juda muhimdir.

Raqobatchilar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Kitov Pharma - Sof foyda bo'yicha sotuv rentabelligi|American Oncology Network (AONC) - Sof marja|BeiGene - Sotuvning sof marjinal rentabelligi|Checkpoint Therapeutics, Inc. (CKPT) - Sof foyda bo'yicha sotuv rentabelligi|ELEV (Elevation Oncology, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|iCAD Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi IKNA|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)